✦ LIBER ✦

A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: Factoring in new trials and meta-analysis data

✍ Scribed by Eric J. Topol

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low Molecular Weight Heparin and Unfract

✍ Mai-Trang Le Nguyen; Frederick A. Spencer 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 176 KB

Efficacy and safety of the low-molecular

✍ Murphy, S. A.; Gibson, C. M.; Morrow, D. A.; Van de Werf, F.; Menown, I. B.; Goo 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 656 KB

Evaluating the place of low-molecular-we

✍ James H. Chesebro; FREEK W. A. Verheugt; Frederic Kontny; EDWARD T. A. Fry; Lars 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

The efficacy and safety of low-molecular

✍ Che, D.H.; Cao, J.Y.; Shang, L.H.; Man, Y.C.; Yu, Y. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 1023 KB

Low-molecular-weight heparins for the tr

✍ Wendy Lim; Khalid Al Saleh; James D. Douketis 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Low-molecular-weight heparins vs. unfrac

✍ E. P. NAVARESE; G. DE LUCA; F. CASTRIOTA; M. KOZINSKI; P.A. GURBEL; C. M. GIBSON 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB